Is Obesity a Chronic Disease? Yes—Here's Why That Matters

Medically reviewed by: Kamilah Williams, MD

For decades, the dominant narrative around weight has centered on willpower, personal choice, and discipline. But science has made one thing clear: obesity is not a personal failing—it’s a chronic, relapsing disease driven by complex biological, genetic, and environmental factors. 

Recognizing obesity as a disease is not just a semantic shift—it’s a necessary evolution that opens the door to compassionate, evidence-based care that works for people long-term.

For employers, this redefinition presents both a challenge and an opportunity. Obesity drives significant healthcare costs, increases absenteeism, and reduces workforce productivity. But with the right tools and support, it’s possible to help employees achieve lasting improvements in weight and metabolic health—transforming outcomes for individuals and organizations alike.

Learn more about Calibrate for employers.

Why obesity is classified as a chronic disease

Obesity meets all the clinical criteria of a chronic disease: it’s persistent, progressive, and associated with significant health risks. Medical organizations including the World Health Organization, the American Medical Association, and the European Commission have formally classified obesity as a chronic disease due to its multifactorial causes and long-term impacts on health​​.

Chronic diseases are defined by their pathophysiology and their long-term consequences—not by whether they are self-inflicted or visible. Obesity results from a variety of factors, including: 

• Long-term energy imbalance: This means that, over time, the body consistently takes in more energy (calories) than it uses, leading to the gradual accumulation of excess fat—even when eating patterns or physical activity levels don't seem extreme. 
• Inherited biology: Genetics play a major role in determining how the body stores fat, regulates appetite, and responds to lifestyle changes.
• Hormone signaling: Hormones like insulin, leptin, and ghrelin influence hunger, satiety, and metabolism, and imbalances can make weight regulation more difficult.
• Environmental conditions: Factors like food availability, sleep disruption, chronic stress, and limited access to safe spaces for physical activity can all contribute to weight gain over time.

In other words, it’s not just about lifestyle choices—and this distinction matters. 

Treating obesity as a chronic disease allows it to be addressed through systemic, medically appropriate channels, just like diabetes or hypertension. It helps reduce stigma and enables employers and healthcare systems to take targeted, proactive steps toward prevention, treatment, and long-term management.

The costs of ignoring obesity as a disease

The health consequences of untreated obesity are serious. It’s a leading driver of more than 200 chronic conditions, including cardiovascular disease, type 2 diabetes, stroke, osteoarthritis, sleep apnea, and certain cancers​. In the workplace, the impact is tangible:

• Employees with obesity incur nearly twice the medical costs of employees with a healthy weight​
• In one study, working adults with obesity missed 66% more days of work per year than their peers with normal weight, with an average of 3.8 additional days of absenteeism annually
• The same study found that adults with obesity also had 40% higher odds of being absent from work—even after adjusting for sex and type of work

Obesity also leads to disruptions in key metabolic markers—including blood sugar (HbA1c), insulin levels, cholesterol, liver enzymes, and inflammation markers like hs-CRP—all of which are linked to long-term risk of chronic disease. Improvements in these markers are strongly associated with reduced cardiovascular risk, better glycemic control, and lower overall healthcare utilization.

The reality is that obesity isn’t a standalone issue—but employers that treat obesity seriously see improvements not only in employee health, but also in organizational performance and healthcare spend.

How obesity treatment has changed since its classification as a disease

Before obesity was recognized as a chronic disease, the U.S. healthcare system largely treated it as a matter of personal responsibility. Individuals were encouraged to rely on willpower, restrictive diets, or increased physical activity—often without any medical support. 

Obesity was framed as a character flaw rather than a medical condition, which led to widespread stigma, minimal research funding, and a lack of insurance coverage for effective treatments. Clinicians received little training in obesity care, and employers had few vetted options to support affected employees.

Now that major medical organizations have formally classified obesity as a chronic, relapsing disease, the framework has begun to shift:

This recognition has helped move the conversation away from blame and toward biology, paving the way for evidence-based treatments such as GLP-1 medications, targeted metabolic interventions, and structured behavior change programs. It has also begun to influence policy, insurance reimbursement, and investment in long-term solutions.

While significant gaps in access and coverage remain, treating obesity as a chronic disease has catalyzed progress in how it is understood, managed, and reimbursed—creating opportunities for more consistent, compassionate, and clinically effective care.

Calibrate offers a comprehensive, biology-based approach to obesity care

GLP-1 medications—such as Ozempic® (semaglutide), Wegovy® (semaglutide), Zepbound® (tirzepatide), Trulicity® (dulaglutide), and others—have proven unprecedentedly successful in helping people lose weight. But medication alone isn’t the answer. The body is wired to resist weight loss—by slowing metabolism, increasing hunger hormones, and reducing fullness signals—even when someone is taking a GLP-1​.

At Calibrate, we go beyond the prescription. Our Metabolic Reset program combines FDA-approved GLP-1 medications with a comprehensive lifestyle curriculum, behavior change nudges and 1:1 coaching. This integrated approach addresses the full spectrum of obesity’s drivers: biology, behavior, environment, and support.

The results speak for themselves:

• Average 16.4% weight loss at 12 months, sustained at 19.1% at 36 months​
• 87% of members report improved quality of life, and 86% say their metabolic health is better​
• Members who completed the Metabolic Reset without GLP-1s still lost an average of 9% of their body weight, underscoring the value of the full program​

Changing the way the world treats weight—together

The classification of obesity as a chronic disease is not just a medical milestone—it’s a mandate for action. Employers have a critical role to play in shifting the conversation around weight from blame to biology. That starts with offering benefits that reflect the latest science and prioritize sustainable, whole-person health.

Calibrate partners with organizations across the country to deliver a scalable, high-impact solution to obesity treatment. By combining the power of GLP-1s with behavioral science, coaching, and a focus on metabolic health, we help employees achieve results that last—and that transform their health far beyond the number on the scale.

Want to learn how Calibrate can support your organization’s health goals? Contact us to learn more about our enterprise solutions.

Sources

European Commission. (2021). Obesity classified as a chronic relapsing disease. The Lancet Diabetes & Endocrinology, 9(7), 418. https://doi.org/10.1016/S2213-8587(21)00145-5

Destri, K., Alves, J., Gregório, M. J., Dias, S. S., Henriques, A. R., Mendonça, N., Canhão, H., & Rodrigues, A. M. (2022). Obesity- attributable costs of absenteeism among working adults in Portugal. BMC public health, 22(1), 978. https://doi.org/10.1186/s12889-022-13337-z 

Jastreboff, A. M., et al. (2019). Obesity as a Disease: The Obesity Society 2018 Position Statement. Obesity, 27(1), 7–9. https://doi.org/10.1002/oby.22378

Rippe, J. M., Crossley, S., & Ringer, R. (1998). Obesity as a Chronic Disease: Modern Medical and Lifestyle Management. Journal of the American Dietetic Association, 98(10), S9–S15. https://doi.org/10.1016/S0002-8223(98)00704-4

Calibrate Health. (2025). 2025 Results Report. Calibrate Health, Inc. https://www.joincalibrate.com

Calibrate Health. (n.d.). It’s not willpower. It’s biology.https://www.joincalibrate.com/resources/its-not-willpower-its-biology